» Articles » PMID: 37830071

A Life-threatening Presentation of Postgastrectomy Exocrine Pancreatic Insufficiency: A Case Report

Overview
Journal Clin Case Rep
Date 2023 Oct 13
PMID 37830071
Authors
Affiliations
Soon will be listed here.
Abstract

Key Clinical Message: Physicians must be alert for the exocrine pancreatic insufficiency diagnosis through the follow-up of postgastrectomy patients, regardless the severity and lag time. Urgent albumin and pancreatic enzyme replacement should be considered when diagnosed.

Abstract: It is documented that exocrine pancreatic insufficiency (EPI) can develop after gastrectomy. Steatorrhea, malnutrition, and weight loss are common symptoms of the disease; however, it is usually mild to moderate postgastrectomy. This article reports a case of EPI manifested by hypoalbuminemia leading to dyspnea and anasarca, which are not typical symptoms of postgastrectomy EPI. A 61-year-old man with a history of gastric adenocarcinoma treated by total gastrectomy and chemoradiotherapy was admitted to the hospital with dyspnea and anasarca. Despite being diagnosed as a case of malignancy recurrence in another hospital, based on the symptoms described, no evidence of malignancy was found. His ascites and pleural effusion were determined to be caused by hypoalbuminemia. In addition, he claimed steatorrhea, and his stool elastase was lower than expected. EPI was diagnosed based on his medical history, paraclinical tests, and examinations. He remained asymptomatic for 1 year after being treated with albumin and pancreatic enzymes. Postgastrectomy EPI may be severe enough to cause steatorrhea or hypoalbuminemia. Hence, regardless of the severity of the presentation, physicians must be alert for this diagnosis throughout the follow-up of patients with a history of gastrectomy. Urgent albumin and pancreatic enzyme replacement should be considered when diagnosed.

Citing Articles

A life-threatening presentation of postgastrectomy exocrine pancreatic insufficiency: A case report.

Rahimipour Anaraki S, Mesgarha M, Bahadorizadeh L, Hassanzadeh M Clin Case Rep. 2023; 11(10):e8037.

PMID: 37830071 PMC: 10565093. DOI: 10.1002/ccr3.8037.

References
1.
Xu R, Gu Q, Xiao S, Zhao P, Ding Z . Patient-reported gastrointestinal symptoms following surgery for gastric cancer and the relative risk factors. Front Oncol. 2022; 12:951485. PMC: 9516295. DOI: 10.3389/fonc.2022.951485. View

2.
Panda S, Sahoo P, Agarwala S, Houghton T T, Chandrapattan P, Sankar K V . Evolution of treatment in gastric cancer- a systematic review. J Egypt Natl Canc Inst. 2022; 34(1):12. DOI: 10.1186/s43046-022-00114-7. View

3.
Bhatia M, Thomas B, Chatu S, El-Hasani S . A 53-Year-Old Man Presenting with Pancreatic Exocrine Insufficiency 7 Years After Gastric Bypass Bariatric Surgery. Am J Case Rep. 2022; 23:e936880. PMC: 9252308. DOI: 10.12659/AJCR.936880. View

4.
Walther B, Clementsson C, Vallgren S, Ihse I, Akesson B . Fat malabsorption in patients before and after total gastrectomy, studied by the triolein breath test. Scand J Gastroenterol. 1989; 24(3):309-14. DOI: 10.3109/00365528909093052. View

5.
Surmelioglu A, Ozkardesler E, Tilki M, Yekrek M . Exocrine pancreatic insufficiency in long-term follow-up after curative gastric resection with D2 lymphadenectomy: A cross-sectional study. Pancreatology. 2021; 21(5):975-982. DOI: 10.1016/j.pan.2021.03.019. View